Insights into the structure and function of membrane polypeptides carrying blood group antigens

Vox Sanguinis

Volumn 74, Issue SUPPL. 2, 1998, Pages 29-64

  Cartron, J P ^a   Bailly, P ^a   Le Van Kim, C ^a   Cherif Zahar, B ^a   Matassi, G ^a   Bertrand, O ^a   Colin, Y ^a  

^a INSTITUT NATIONAL DE LA TRANSFUSION SANGUINE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD GROUP ANTIGEN; LIGAND;

BLOOD GROUP SYSTEM; CONFERENCE PAPER; GENETIC POLYMORPHISM; MOLECULAR GENETICS; PRIORITY JOURNAL; STRUCTURE ACTIVITY RELATION;

EID: 0031818740     PISSN: 00429007     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1423-0410.1998.tb05397.x     Document Type: Conference Paper

References (304)

1. Lowe JB: Molecular cloning, expression and uses of mammalian glycosyltransferases. Semin Cell Biol 1991;2:289-307.
2. Lowe JB: The blood group-specific human glycosyltransferases. Baillières Clinical Haematology 1993;6:465-492.
3. Clausen H, Bennett EP, Grunnet N: Molecular genetics of ABO histo-blood groups. Transf Clin Biol 1994;2:79-89.
4. Yamamoto F: Molecular genetics of the ABO histo-blood group system. Vox Sang 1995;69:1-7.
5. Mollicone R, Candelier JJ, Reguine I, Couillin P, Fletcher A, Oriol R: Molecular genetics of -L-fucosyltransferase genes (H, Se, Le, FUT4, FUT5 and FUT6). Transfus Clin Biol 1994;2:91-97.
6. Costache M, Cailleau A, Fernandez-Mateos P, Oriol R, Mollicone R: Advances in mo lecular genetics of α-2- and α-3/4-fucosyltransferases. Transf Clin Biol 1997;4:367- 382.
7. Anstee DJ: Minor red cell surface proteins associated with red cell dysfunction. Baillière's Clinical Haematology 1993;6:445- 463.
8. Anstee DJ, Spring FA, Parsons SF et al. : Molecular background of human blood group antigens. In "Human Genetics 1994: a revo lution in full swing " (Hackel E, Tippett P, eds), pp. 1-51, American Association of Blood Banks, Bethesda, MD, 1994
9. Anstee DJ: Blood group antigens defined by the amino acid sequences of red cell surface proteins.Transfus Medicine 1995;5:1-13.
10. Telen MJ: Erythrocyte blood group antigens: not so simple after all. Blood 1995;85:299- 306.
11. Lublin DM: Functional roles of blood group antigens. In "Molecular and functional aspects of blood group antigens " (Silberstein LE, ed), pp. 163-1192, American Association of Blood Banks, Bethesda, MD, 1995.
12. Mudad R, Telen J: Biological functions of blood group antigens. Cur Op Hematol 1996; 3:473-479.
13. Cartron JP: Vers une approche moléculaire de la structure, du polymorphisme et de la fonction des antigènes de groupes sanguins. Transf Clin Biol 1996;3:181-210.
14. Cartron JP: Groupes sanguins et relation structure-fonction. Transf Clin Biol 1998;5(suppl 1):S9-S32.
15. Anstee DJ, Cartron JP: Towards an understanding of the red cell surface. In "Applications of Molecular Biology to Blood Transfusion Medicine" (G. Garratty, ed), pp. 17- 49, American Association of Blood Banks, Bethesda, MD, 1997
16. Telen MJ: Blood group antigens on complement receptor/regulatory proteins. Transfusion Med Reviews 1995;9:20-28.
17. Tanner MJA: Molecular and cellular biology of the erythrocyte anion exchanger (AE1). Semin Hematol 1993;30:34-57.
18. Bennett V: The spectrin-actin junction of erythrocyte membrane sheleton. Biochim Biophys Acta 1989;988:107-121.
19. Palek J, Lambert S: Genetics of the red cell membrane skeleton. Semin Hematol 1990;27:290-332.
20. Crandall I, Collins WE, Gysin J, Sherman IW: Synthetic peptides based on motifs present in human band 3 protein inhibit cytoadherence/sequestration of the malaria parasite Plasmodium falciparum. Proc Natl Acad Sci (USA) 1993;90:4703-4707.
21. Oh SS, Chisthi AH, Palek JP, Liu SC: Erythrocyte membrane alterations in Plasmodium falciparum malaria séquestration. Cur Op Hematol 1997;4:148-154.
22. Daniels G, Anstee DJ, Cartron JP, Dahr W, Issitt PD, Jorgensen J, Komstad L, Levene C, et al: Blood group terminology 1995. ISBT Working party on terminology of red cell surface antigens, Vox Sang 1995;69:265-279.
23. King LS, Agre P: Pathophysiology of the aquaporin water channels. Annu Rev Physiol 1996;58:619-648.
24. Zelinski T: Erythrocyte Band 3 antigens and the Diego blood group system. Transf Med Reviews 1998;12:36-45.
25. Tanner MJA: Advances in the molecular biology of erythrocyte antigens. Cur Op Hematol 1995;2:139-145.
26. Pasvol G, Clough B, Carlsson J: Malaria and the red cell membrane. Blood Reviews 1992;6:183-192.
27. Garratty G: Blood group antigens as tumor markers, parasitic/bacterial/viral receptors, and their association with immunologically important proteins. Immunol Invest 1995;24:213-232.
28. Moulds JM, Nowicki S, Moulds JJ, Nowicki BJ: Human blood groups: incidental receptors for viruses and bacteria. Transfusion 1996;36:362-374.
29. Frattali Eder A, Spitalnik SL: Blood group antigens as receptors for pathogens. In " Molecular biology and evolution of blood group and MHC antigens in Primates " (Blancher A, Klein, Socha, eds), pp.268-304, Springer, Berlin, 1997
30. Varki A: Sialic acids as ligand in recognition phenomena. FASEB J 1997;248:248-255.
31. Brown KE, Anderson SM, Young NS: Erythrocyte P antigen: cellular receptor for B19 parvovirus. Science 1993;262;114-117.
32. Carper E, Kurtzman GJ: Human parvorirus B19 infection. Cur Op Hematol 1996:3:111- 117.
33. Karlsson KA: Animal glycosphingolipids as membrane attachment sites for bacteria. Annu Rev Biochem 1989;58:309-350.
34. Saadi A, Weir DM, Poxton IR, Stewart J; Essery SD, Blackwell CC, Raza MW, Busuttil A: Isolation of an adhesin from Staphylococcus aureus that binds Lewisa blood group antigen and its relevance to sudden infant death syndrome. FEMS Immunology and Medical Microbiology 1994;8:315-320.
35. Borén T, Falk P, Roth KA, Larson G, Normark S: Attachment of Helicobacter pylori to human gastric epithelium mediated by blood group antigen. Science 1993;262:1892-1895.
36. Chitnis CE, Chaidhuri A, Horuk R, Pogo AO, Miller LH: The domain on the Duffy blood group antigen for binding Plasmodium vivax and P. knowlesi malarial parasites to erythrocytes. J Exp Med 1996;184:1531-1536.
37. Rowe JA, Moulds JM, Newbold CI, Miller LH: P. falciparum resetting mediated by a parasite-variant erythrocyte membrane protein and complement-receptor 1. Nature 1997;338:292-295.
38. Berendt Ar, Ferguson DJP, Newbold CI: Sequestration in Plasmodium falciparum malaria: sticky cells and sticky problems. Parasitol Today 1990;6:247-254.
39. Ward GE, Chitnis CE, Miller LH: The invasion of erythrocytes by malarial merozoites. Baillère's Clinical Infectious Diseases 1994;1:155-190.
40. Haynes BF, Lia HX, Patton KL: The transmembrane hyaluronate receptor (CD44): Multiple functions, multiple forms. Cancer Cells 1991;3:347-350.
41. Borland G, Ross JA, Guy K: Forms and functions of CD44. Immunology 1998;93:139-148.
42. Ellis NA Tippett P, Petty A, Reid M, Weller PA, Ye TZ, German J, Goodfellow PN, Thomas S, Banting G: PBDX is the XG blood group gene. Nature Genet 1994;8:285- 290.
43. Spring FA, Holmes CH, Simpson KL, Mawby WJ, Mattes MJ, Okubo Y, Parsons SF: The Oka blood group antigen is a marker for the M6 leukocyte activation antigen, the human homolog of OX-47 antigen, basigin and neurothelin, an immunoglobulin super- family molecule that is widely expressed in human cells and tissues. Eur J Immunol 1997;27:891-897.
44. Watkins WM; Biochemistry and genetics of the ABO, Lewis, and P blood group systems. in "Advances in human genetics" (H Harris, K Hirschlorn, eds) pp. 1-136, Plenum Press, New York, 1980
45. Bartels CF, Zelinski T, Lockridge O: Mutation at codon 322 in the human acetylcholinesterase (AChE) gene accounts for YT blood group polymorphism. Am J Hum Genet 1993;52:928-936.
46. Rosse WF, Ware RE: The molecular basis of paroxysmal nocturnal hemoglobinuria, Blood 1995;86:3277-3286.
47. Cartron JP, Rahuel C: Human erythrocyte glycophorins: protein and gene structure analysis. Transf Med Reviews 1992;6:63-92.
48. Fukuda M: Molecular genetics of the glycophorin A gene cluster. Semin Hematol 1993;30:138-151.
49. Huang CH, Blumenfeld OO: MNSs blood group and major glycophorins. In "Molecular basis of major human blood groups antigens" (JP Cartron, P Rouger, eds), Blood Cell Biochemistry vol 6, pp. 153-188, Plenum Press, New York ", 1995
50. Tomita A, Radike EL, Parker CJ: Isolation of erythrocyte membane inhibitor of reactive lysis type II. J Immunol 1993;151:3308-3323.
51. Chasis JA, Mohandas N: The role of red cell glycophorins in regulating membrane function, in "Protein blood group antigens of the human red cell" (Agre P, Cartron JP, eds), pp152-169, Johns Hopkins University Press, Baltimore, 1992.
52. Anstee DJ, Ridgwell K, Tanner MJA, Daniels GL, Parsons SF: Individuals lacking the Gerbich blood-group antigen have alterations in the human erythrocyte membrane sialoglyco- proteins and Biochem J 1984;221:97- 104.
53. Le Van Kim C, Piller V, Cartron JP, Colin Y: Glycophorins C and D are generated by the use of alternative translation initiation sites. Blood 1996;88:2364-2365.
54. Cartron JP, Le Van Kim C, Colin Y: Glycophorin C and related glycoproteins: structure, function and regulation. Semin Haematol 1993;30:152-168.
55. Allosio N, Dalla Venezia N, Rana A, andrabi K, Texier P, Gilsanz F, Cartron JP, Delaunay J, Chishti AH: Evidence that the red blood cell protein p55 may participate in the skeleton-membrane linkage that involves protein 4.1 and glycophorin C. Blood 1993;82;1323- 1327.
56. Ruff P, Speicher DW, Husain-Chishti A: Molecular identification of a major palmitoylated erythrocyte membrane protein containing the src homology 3 motif. Proc Natl Acad Sci (USA) 1991;88:6595-6599.
57. Marfatia SM, Lue RA, Branton D, Chisthi AH: Identification of the protein 4.1 binding interface on glycophorin C and p55, a homologue of the Drosophila disc-1 arge tumor suppressor protein. J Biol Chem 1995;270:715-719.
58. Marfatia SM, Morais-Cabral JH, Kim AC, Byron O, Chishti AH: The PDZ domain of human erythrocyte p55 mediates its binding to the cytoplasmic carboxyl terminus of glycophorin C. Analysis of the binding interface by in vitro mutagenesis. J Biol Chem 1997;272:24191-24197.
59. Hemming NJ, Anstee DJ, Staricoff MA, Tanner MJA, Mohandas N: Identification of the membrane attachment sites for protein 4.1 in human erythrocytes. J Biol Chem 1995;270:5360-5366.
60. Chishti AH, Palek J, Fisher D, Maalouf FJ, Liu SC: Reduced invasion and growth of Plasmodium falciparum into elliptocytic red blood cells with a combined deficiency of protein 4.1, glycophorin C, and p55. Blood 1996;87:3462-3469.
61. Metzenberg A, Gitschier J: The gene encoding the palmitoylated erythrocyte membrane protein, p55, originates at the CpG island 3' to the factor VIII. Hum Mol Genet 1992;1:97-101.
62. Saras J, Heldin CH; PDZ domains bind carboxy-terminal sequences of target proteins, Trends Biol Sci 1996;21:455-458.
63. Levine, P., and Stetson, R.E., 1939, An unusual case of intragroup agglutination, JAMA 113:126-127.
64. Levine P, Burnham L, Katzin EM, Vogel P: The role of iso-immunization in the pathogenesis of erythroblastosis fetalis. Am J Obstet Gynecol 1941a;42:925-937.
65. Levine P, Katzin EM, Burnham L: Isoimmunization in pregnancy, its possible bearing on the etiology of erythroblastosis fetalis. J Am Med Assoc 1941b;116:825-827.
66. Bowman JM: Hemlytic disease of the new- born. In "Immunobiology of Transfusion Medicine" (Garratty G, ed), pp.553-595, M Dekker Publications, New York, 1994.
67. Race RR, Sanger R: Blood Groups in Man, 6th ed. Oxford, Blackwell, 1975
68. 068Mollison PL, Engelfriet CP, Contreras M: Blood Transfusion in Clinical Medicine, 9th ed, Oxford, Blackwell, 1993
69. Rosse W: Autoimmune disease due to warm- reacting antibodies: immune hemolytic anemia. In Clinical Immunohematology: basic concepts and clinical applications, pp. 519- 32. Blackwell Scientific, Boston, 1990
70. Schmidt PJ, Vos GH: Multiple phenotypic abnormalities associated with Rh-null (---/--). Vox Sang 1967;13:18-20.
71. Sturgeon P: Hematological observations on the anemia associated with blood type Rhnull. Blood 1970;36:310-320.
72. Green FA: Studies on the Rh(D) antigen. Vox Sanguinis 1965;10:32-53.
73. Green FA: Erythrocyte membrane sulfhydryl groups and Rh antigen activity. Immunochemistry 1967;4:247-257.
74. Green FA: Phospholipid requirements for Rh antigenic activity. J Biol Chem 1968;243:5519-5524.
75. Green FA: Erythrocyte membrane lipids and Rh antigen activity. J Biol Chem 1972;247:881-887.
76. Moore S, Woodrow CF, McClelland: Isolation of membrane components associated with human red cell antigens Rho(D), (c), (E), and Fya. Nature 1982;295:529
77. Gahmberg CG: Molecular identification of the human Rho(D)-antigen, FEBS Lett 1982;140:93-97.
78. Gahmberg CG, Khari KK: Association of Rh(D) polypeptides with the membrane skeleton in Rh(D) positive cells. J Immunol 1984;133:334-337.
79. Ridgwell K, Tanner MJA, Anstee DJ: The rhesus (D) polypeptide is linked to the human erythrocyte cytoskeleton. FEBS Lett 1984;174:7-10.
80. Moore S, Green C: The identification of specific Rhesus polypeptide blood group ABH active glycoprotein complexes in the human red cell membrane. Biochem J 1987;244:735-741.
81. Gahmberg CG: Molecular characterization of the human red cell Rh0(D) antigen. EMBO J 1983;2:223-227.
82. von dem Borne AEG, Bos MJE, Lomas C, Tippett P, Bloy C, Hermand P, Cartron JP, Admiraal LG, van de Graaf J, Overbeeke MAM: Murine monoclonal antibodies against a unique determinant of erythrocytes related to Rh and U antigens. Br J Haematol 1990;75:254-261.
83. Mallinson G, Anstee DJ, Avent ND, Ridgwell K, Tanner MJA, Daniels GL, Tippett P, Von dem Borne AEG: Murine monoclonal antibody MB-2D10 recognizes Rh-related glycoproteins in the human red cell membrane. Transfusion 1990;30:222-225.
84. Agre P, Cartron JP: Molecular biology of Rh antigens. Blood 1991;78:551-563.
85. Cartron JP, Agre P: Rh blood group antigens: protein and gene structure. Semin Hematol 1993;30:193-208.
86. Anstee DJ, Tanner MJ: Biochemical aspects of the blood group Rh (rhesus) antigens. Baillière's Clin Haematol 1993;6:401-422.
87. Cartron JP: Defining the Rh blood group antigens. Biochemistry and molecular genetics. Blood Reviews 1994;8:199-212.
88. Cartron JP, Colin Y: Bases moléculaires du système RH et syndrome Rhnull. Hématologie 1997;3:207-220.
89. Huang CH: Molecular insights into the Rh protein family and associated antigens. Cur Op Haematol 1997;4:94-103.
90. Matassi G, Cherif-Zahar B, Raynal V, Rouger P, Cartron JP: Organization of the human RH50A gene (RHAG) and evolution of base composition of the RH gene family. Genomics 1998;47:286-293.
91. Huang CH: The human Rh50 glycoprotein gene. Structural organization and associated splicing defect resulting in Rh(null) disease. J Biol Chem 1998;273:2207-2213.
92. Carritt B, Kemp TJ, Poulter M: Evolution of the human RH (rhesus) blood group genes: a 50 year old prediction (partially) fultilled. Hum Mol Genet 1997;6:843-850.
93. Avent ND: Immunochemistry and protein chemistry of the Rh polypeptides in normal and variant phenotype erythrocytes. Biotest Bull 1997:5:415-428.
94. deVetten MP, Agre P: The Rh polypeptide is a major fatty acid acylated erythrocyte membrane protein. J Biol Chem 1988;263:18193- 18196.
95. Hartel-Schenk S, Agre P, Mammalian red cell membrane Rh polypeptides are selectively palmitoylated subunits of a macro- molecular complex. J Biol Chem 1992;267:5569-54.
96. Dahr W, Schmitz G, Ernst M, Gielen W, Sonneborn HH: Rh antigens and cysteine modification. Biotest Bull 1997;5:451-457.
97. Suyama K, Lunn R, Goldstein J: Red cell surface cysteine residue (285) of D polypeptide is not essential for D antigenicity. Transfusion 1995;35:653-659.
98. Smythe JS, Anstee DJ: K562 cells expressing RhD polypeptide with a Cys285 to Ala mutation have a normal D antigen. Transf Med 1997:7(suppl 1):29(abstr.).
99. Paradis G, Bazin R, Lemieux R: Protective effect of the membrane skeleton on the immunologic reactivity of the human red cell Rho (D) antigen. J Immunol 1986;137:240-4.
100. Dahr W, Kordowicz M, Moulds J, Gielen W. Lebeck L, Krueger J: Characterization of the Ss sialoglycoprotein and its antigens in Rh- null erythrocytes. Blut 1987;54:13-24.
101. Cartron JP: Recent advances in the biochemistry of blood group antigens, in "Monoclonal antibodies against human red blood cell and related antigens" (Rouger P, Salmon Ch, eds) pp.69-97, Librairie Arnette, Paris, 1987.
102. Ridgwell K, Eyers S, Mawby WJ, Anstee DJ, Tanner MJA: Studies on the glycoprotein associated with Rh (Rhesus) blood group antigen expression in the human red blood cell membrane. J Biol Chem 1994;269;6410- 6416.
103. Tippett P: Regulator genes affecting red cell antigens. Transf. Med Reviews 1990;l:56-68.
104. Eyers SA, Ridgwell K, Mawby WJ, Tanner MJA; Topology and organization of human Rh (Rhesus) blood group-related polypeptides. J Biol Chem 1994;269:6417-6423.
105. Colin Y, Chérif-Zahar B, Le Van Kim C, Raynal V, Van Huffel V, Cartron JP: Genetic basis of the RhD-positive and RhD-negative blood group polymorphism. Blood 1991;78:2747-52.
106. Hyland CA, Wolter LC, Saul, A: Three unrelated Rh D gene polymorphisms identified among blood donors with rhesus Ccee (r'r') phenotypes, Blood 1994;84:321-324.
107. Blunt T, Daniels G, Carritt B: Serotype switching in a partially deleted RhD gene. Vox Sang 1994;67:397-401.
108. Umenishi F, Kajii E, Ikemoto S: Molecular analysis of Rh polypeptides in a family with RhD-positive and RhD-negative phenotypes. Biochem J 1994;299:207-211.
109. Huang CH. Alteration of RH gene structure and expression in human dCCee and DCw- red blood cells: phenotypic homozygosity versus genotypic heterozygosity. Blood 1996:88:2326-2333.
110. Avent ND, Martin PG, Armstrong-Fisher SS, Liu W, Finning KM, Maddocks D, Urbaniak SJ: Evidence of genetic diversity underlying Rh D-, weak D (Du), and partial D pheno- types as determined by multiplex polymerase chain reaction analysis of the RHD gene. Blood 1997;89:2568-2577.
111. Aubin JT, Le Van Kim C, Mouro I, Colin Y, Bignozzi C, Brossard Y, Cartron JP. Specificity and sensitivity of RHD genotyping methods by PCR-based DNA amplification. Br J Haematol 1997;98:356-364.
112. Okuda H, Kawano M, Iwamoto S, Tanaka M., Seno T, Okubo Y, Kajii E; The RHD gene is highly detectable in RhD-negative japanese donors. J Clin. Invest. 1997;100:373-379.
113. Chérif-Zahar B, Bony V, Steffensen R, Gane P, Goossens D, Raynal V, Laursen J, Vanning K, Jersild C, Cartron JP; Shift from Rh-positive to Rh-negative phenotype caused by a somatic mutation within the RHD gene in a patient with chronic myelocytic leukemia. submitted.
114. Rouillac C, Gane P, Cartron J, Le Pennec PY, Cartron JP, Colin Y: Molecular basis of the altered antigenic expression of RhD in weak D (Du) and RhC/e in RN phenotypes. Blood 1996;87:4853-4861.
115. Seekers EAM, Faas BHW, Ligthart P, Over- beele MAM, von dem Some AEG, van der Schoot CE, van Rhenen DJ: Lower antigen site density and weak D immunogeninity cannot be explaine by structural abnormalities or regulatory defects of the RHD gene. Transfusion 1997;37:616-623.
116. Mouro I, Colin Y, Chérif-Zahar B, Cartron JP, Le Van Kim C: Molecular genetic basis of the human Rhesus blood group system. Nature Genet 1993;5:62-65.
117. Salvignol I, Calvas P, Socha WW, Colin Y, Le Van Kim C, Bailly P, Ruffle J, Cartron JP, Blancher A: Structural analysis of the RH- like blood group gene products in nonhuman primates. Immunogenet 1995;41:271-281.
118. Smythe JS, Avent ND, Judson PA, Parsons SF, Martin PG, Anstee DJ: Expression of RHD and RHCE gene products using retroviral transduction of K562 cells establishes the molecular basis of Rh blood group antigens. Blood 1996;87:1968-1973.
119. Mouro I, Colin Y, Gane P, Collec E, Zelinski T, Cartron JP, Le van Kim C: Molecular analysis of blood group Rh transcripts from a rGr variant.Br J Haematol 1996;93:472-474.
120. Apoil PA, Reid ME, Halverson G, Mouro I, Colin Y, Roubinet F, Cartron JP, Blancher A: A human monoclonal anti-D antibody which detects a nonconformation-dependent epitope on the RhD protein by immunoblotting. Br J Haematol 1997;98:365-374.
121. Tippett P, Lomas-Francis C, Wallace M: The Rh antigen D: partial D antigens and associated low incidence antigens. Vox Sang 1996;70:123-131.
122. Jones J, Scott ML, Voak D: Monoclonal anti- D specificity and RhD structure: criteria for selection of monoclonal anti-D reagents for routine typing of patients and donors. Transf Med 1995;5:171-84.
123. Scott ML, Voak D, Jones JW, Avent ND, Liu W, Hughes-Jones NC, Sonneborn HH: A structural model for 30 RhD epitopes based on serological and DNA sequence data from partial D phenotypes. Transf Clin Biol 1996:6:391-396.
124. Faas BHW, Seekers EAM, Maaskant-van Wijk PA, Overbeecke MAM, van Rhenen DJ, AEG Kr von dem Borne, van der Schoot CE: Molecular characterization of Rh qualitative variants. Biotest Bull 1997;5:439-449.
125. Avent ND, Finning KM, Liu W, Scott ML: Molecular biology of partial D phenotypes. Transf Clin Biol 1996;6:511-516.
126. Wagner FF, Gassner C, Müller TH, Schönitzer D, Schunter F, Flegel WA: Three mo lecular structure cause Rhesus D category VI phenotypes with distinct immunohematologic features, Blood 1998;91:2157-2168.
127. Daniels GL: Low frequency antigens associated with Rh: markers for genetic variants. Biotest Bull 1997;5:300-407.
128. Huang CH, Reid ME, Chen Y, Novaretti M: Defect of Arg229 in RHCE polypeptide alters expression of RHE and CE- associated Rh6 antigens. Blood 1997;90 (suppl 1, part 1):272a (abstr.).
129. Daniels G : Human Blood Groups. Blackwell Science Ltd, Oxford, 1995.
130. Noizat-Pirenne F, Mouro I, Gane P, Okubo Y, Hori Y, Rouger P, Le Pennec PY, Cartron JP: Heterogeneity of blood group RhE variants reveales by serological analysis and molecular alteration of RHCE gene and transcript. Submitted.
131. Cartron JP, Rouillac C, Le van Kim C, Mouro I, Colin Y. Tentative model for the mapping of D epitopes on the RhD polypeptide. Transf Clin Biol 1996;6:497-503.
132. Scott ML, Voak D, Jones JW, Liu W, Avent ND, Hughes-Jones NC, Sonnebom HH; A model for RhD - the relationship of serologically defined 30 epitopes to predicted structures. Biotest Bull 1997;5:459-466.
133. Lomas C, Tippett P, Thompson KM, Melamed MD, Hughes-Jones NC: Demonstration of seven epitopes on the Rh antigen D using human monoclonal antiD antibodies and red cells from D categories. Vox Sang 1989;57:261-264.
134. Smythe JS, Anstee DJ: Expression of RHD and RHCE gene products using retroviral transduction of K562 cells and the use of site- directed mutagenesis to establish the molecular basis of Rh blood group antigens. Biotest Bull 1997;5:467-473.
135. Mouro I, Raynal V, Gane P, Le Van Kim C, Blancher A, Cartron JP, Colin Y: Expression of the RhD antigen in K562 cells after a standard transfection procedure coupled with magnetic beads sorting technique. Vox Sang (suppl 1), this issue (abstr. XXV ISBT Congress, Oslo, June 27-July 2), 1998.
136. Chang TY, Siegel DL: Genetic and immunological properties of phage-displayed human anti-Rh(D) antibodies: implications for Rh(D) epitope topology. Blood 1998;91:3066-3078.
137. Bernardi G: The human genome: organization and evolutionary history. Annu Rev Genet 1995;29:445-476.
138. Zoubak S, Clay O, Bernardi G: The gene distribution of the human genome. Gene 1996;174:95-102.
139. Blancher A, Socha WW; The Rhesus system. In "Molecular biology and evolution of blood group and MHC antigens in primates" (Blancher A, Klein J, Socha WW, eds), pp.147-218, Springer-Verlag, Berlin, 1997.
140. Socha WW, Ruffié J: The Rhesus system, In "Blood groups of Primates: Theory, Practice, and Evolutionary Meaning". pp. 75-90, Alan R. Liss, New York, 1983.
141. Fisher RA: The Rhesus factor. Amer Sci 1947;35:95-102,113.
142. Feldman MW, Nabholz M, Bodmer WF: Evolution of the Rh polymorphism ; A model for the interaction of incompatibility, repro ductive compensation, and hétérozygote advantage. Am J Hum Genet 1969;21:171-173.
143. Matassi G, Cherif-Zahar B, Mouro I, Cartron JP: Characterization of the recombination hot spot involved in the genomic rearrangement leading to the hybrid D-CE-D gene in the D(VI) phenotype. Am J Hum Genet 1997;60:808-817.
144. Kemp TJ, Poulter M, Carritt B: A recombination hot spot in the Rh genes revealed by analysis of unrelated donors with the rare D - phenotype [published erratum appears in Am J Hum Genet 1997;60:749], Am J Hum Genet 1996;59:1066-1073.
145. Saitou N, Nei M: The neighbor-joining method: a new method for reconstructing phylogenetic trees. Mol Biol Evol 1987;4:406-425.
146. Thompson JD, Higgins DG, Gibson TJ: CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res 1994;22:4673-4680.
147. Galtier N, Gouy M, Gautier C: SEAVIEW and PHYLO_WIN: two graphic tools for sequence alignment and molecular phylogeny. Comput Appl Biosci 1996;12:543-548.
148. Seack J, Pancer Z, Müller IM, Müller WEG: Molecular cloning and primary structure of a Rhesus (Rh)-like protein from the marine sponge Geodia cynodium. Immunogenet 1997;46:493-498.
149. Westhoff CM, Wylie DE: Investigation of the human Rh blood group system in nonhuman primates and other species with serologic and Southern blot analysis. J Mol Evol 1994;39:87-92.
150. Marini AM, Urrestarazu A, Beauwens R, Andre B: The Rh (rhesus) blood group polypeptides are related to NH4+ transporters. Trends Biochem Sci 1997;22:460-461.
151. Nash R, Shojania AM. Hematological aspect of Rh deficiency syndrome: a case report and review of the literature. Am J Hematol 1987;24:267-275.
152. Palek J, Jarolim P. Clinical expression and laboratory detection of red blood cell membrane protein mutations. Semin Hematol 1993;30:249-283.
153. Bailly P, Cartron JP, Wang D, Johnson RM. Hereditary stomatocytosis and Rh-deficient patients exhibit distinct molecular defects. Blood 1992;50:1624-1626.
154. Chérif-Zahar B, Raynal V, Gane P, Mattei MG, Bailly P, Gibbs B, Colin Y, Cartron JP: Candidate gene acting as a suppressor of the RH locus in most cases of Rh-deficiency. Nature Genet 1996;12:168-1673.
155. Hyland CA, Chérif-Zahar B, Cowley N, Raynal V, Parkes J, Saul A, Cartron JP: A novel single missense mutation identified along the RH50 gene in a composite heterozygote Rhnull blood donor of the regulator type. Blood 1998;91:1458-1463.
156. Huang CH, Cheng GJ, Liu Z, Reid ME, Chen Y: Rh deficiency syndrome, Rhmod, is caused by mutation of the the translarion initiator ATG in Rh50 glycoprotein gene. Blood 1997;90 (suppl 1, part 1):9a (abstr.).
157. Chérif-Zahar B, Matassi G, Raynal V, Gane P, Delaunay J, Arrizabalaga B, Cartron JP: Rh-deficiency of the regulator type caused by splicing mutations in the human RH50 gene. Blood 1998; in press
158. Chérif-Zahar B, Matassi G, Raynal V, Gane P, Mempel W, Perez C, Cartron JP: Molecular defects of the RHCE gene in Rh-deficient individuals of the amorph type. Blood 1998; in press.
159. Schroit AJ, Bloy C, Connor J, Cartron JP: Involvement of Rh blood group polypeptides in the maintenance of aminophospholipid asymmetry. Biochemistry 1990;29:10303- 10306.
160. Smith RE, Daleke DL: Phosphatidylserine transport in Rhnull erythrocytes. Blood 1990;76:1021-1027.
161. Geldwerth D, Cherif-Zahar B, Helley D, Gane P, Freyssinet JM, Colin Y, Devaux PF, Cartron JP: Phosphatidylserine exposure and aminophospholipid translocase activity in Rh-deficient erythrocytes. Mol Membrane Biol 1997;14:125-132.
162. Mouro I, Schlegel R, Williamson P, Halleck MS, Zakowski A, Devaux P, Cartron JP, Colin Y. Isolement d'un ADNc codant pour une ATPase humaine potentiellement impliquée dans la répartition asymétrique des phospholipides au sein de la membrane des globules rouges. Hématologie 1997;3 (suppl 1):19(abstr.).
163. Heaton DC, McLoughlin K: Jk(a-b-) red blood cells resist urea lysis. Transfusion 1982;22:70-71.
164. Fröhlich O, Macey RI, Edwards-Moulds J, Gargus JJ, Gunn RB: Urea transport deficiency in Jk(a-b-) erythrocytes. Am J Physiol 1991;260:C778-C783.
165. Olivès B, Neau P, Bailly P, Hediger MA, Rousselet G, Cartron JP, Ripoche P: Cloning and functional expression of a urea transporter from human bone marrow cells. J Biol Chem 1994;269:31649-31652.
166. Olivès B, Mattei MG, Huet M, Neau P, Martial S, Cartron JP, Bailly P: Kidd blood group and urea transport function of human erythrocytes are carried by the same protein. J Biol Chem 1995;270:15607-15610.
167. Rousselet G, Bailly P, Ripoche P: Tandem sequence repeats in urea transporters: identification of an urea transporter signature sequence, Am J Physiol 1996;270:F554-F555.
168. Sidoux-Walter F, Olivès B, Martial S, Ripoche P, Cartron JP, Bailly P: Further characterization of human urea transporters. XXXIIIth Intern Congress of Physiol Sciences, June 30-July 5, St Petersbourg, 1997 (abstr).
169. Olivès B, Merriman M, Bailly P, Bain S, Barnett A, Todd J, Cartron JP, Merriman T: The molecular basis of the Kidd blood group polymorphism and its lack of association with type 1 diabetes susceptibility. Hum Mol Genet 1997;6:1017-1020.
170. Hodge SE, Anderson CE, Neiswanger K, Field LL, Spence MA, Sparkes RS, Sparkes M, Christ M, Terasaki PI, Rimoin DL, Rotter JI: Close genetic linkage between diabetes mellitus and Kidd blood group. Lancet 1981;2:893-895.
171. Hodge SE, Anderson CE, Neiswanger K, Sparkes RS, Rimoin DL: The search for heterogeneity in insulin-dependent diabetes mellitus (IDDM): linkage studies, two-locus models, and genetic heterogeneity, Am J Hum Genet 1983;35:1139-1155.
172. Dunsworth TS, Rich SS, Swanson J, Barbosa J: No evidence for linkage between diabetes and the Kidd marker. Diabetes 1982;31:991- 993.
173. Lucien N, Sidoux-Walter F, Olivès B, Moulds J, Le Pennec PY, Cartron JP, Bailly P: Characterization of the gene encoding the human Kidd blood group/urea transporter protein. Evidence for splice site mutations in Jknull individuals. J Biol Chem 1998;273:000-000, in press
174. Sands JM, Timmer RT, Gunn RB: Urea transporters in kidney and erythrocytes. Am J Physiol 1997;273:F321-F339.
175. Moulds JM: The Kidd blood group and urea transport. In" Molecular basis of major human blood group antigens" (Cartron JP, Rouger P, eds) Blood Cell Biochemistry, vol 6 Plenum Press New York, pp.267-278, 1995.
176. Bankir L: Urea and the kidney. In "The Kidney (5th edition)," Brenner BM, Rector FC Jr, eds, Saunders Company, 1995.
177. Gillin AG, Sands JM: Urea transport in the kidney. Semin Nephrol 1993;13:146-154.
178. Hediger MA, Smith CP, You G, Lee WS, Kanai Y, Shayakul C: Structure, regulation and physiological roles of urea transporters. Kidney Intern 1996;49:1615-1623.
179. Xu Y, Olivès B, Bailly P, Fischer E, Ripoche P, Ronco P, Cartron JP, Rondeau E: Endothelial cells of the kidney vasa recta express the urea transporter HUT11. Kidney Int 1997;51:138-146.
180. Pallone TL: Characterization of the urea transporter in outer medullary descending vasa recta. Am J Physiol 1994;267:R260- R267.
181. Promeneur D, Rousselet G, Bankir L, Bailly P, Cartron JP, Ripoche P, Trinh-Trang-Tran, MM: Evidence for distinct vascular and tubular urea transporters in the rat kidney. J Am Soc Nephrol 1996;7:852-860.
182. Sands JM, Gargus JJ, Fröhlich O, Gunn RB, Kokko JP: Urinary concentrating ability in patients with Jk(a-b-) blood type who lack carrier-mediated urea transport. J Am Soc Nephrol 1992;2:1689-1696.
183. Olivès B, Martial S, Mattei MG, Matassi G, Rousselet G, Ripoche P, Cartron JP, Bailly P: Molecular characterization of a new urea transporter in the human kidney. FEBS Lett 1996;386:156-160.
184. Martial S, Olivès B, Abrami L, Couriaud C, Bailly P, You G, Hediger M, Cartron JP, Ripoche P, Rousselet G: Functional differentiation of the human red blood cell and kidney urea transporters. A. J Physiol 1996;271:F1264-F1268.
185. Macey RI, Yousef LW: Osmotic stability of red cells in renal circulation requires rapid urea transport. Am J Physiol 1988;254:C669- C674.
186. Macey RI, Fanner RE: Inhibition of water and solute permeability in human red cells. Bichim Biophys Acta 1970;211:104-106.
187. Mayrand RR, Levitt DG: Urea and ethylene glycol-facilited transport systems in the human red cell membrane: saturation, competi tion and asymmetry. J Gen Physiol 1983;81:221-237.
188. Chaudhuri A, Polyakova J, Zbrzezna V, Williams K, Gulati S, Pogo AO: Cloning of glycoprotein D cDNA, which encodes the major subunit of the Duffy blood group system and the receptor for the Plasmodium vivax malaria parasite. Proc Natl Acad Sci (USA) 1993;90:10793-10797.
189. Neote K, Mak JY, Kolakovski LF, Schall TJ: Functional and biochemical analysis of the cloned Duffy antigen: identity with the red blood cell chemokine receptor. Blood 1994;84:44-52.
190. Toumamille C, Le Van Kim C, Gane P, Blanchard D, Proudfoot AE, Cartron JP, Colin Y: Close association of the first and fourth extracellular domains of the Duffy Antigen/Receptor for Chemokines by a disulfide bond is required for ligand biding. J Biol Chem 1997;272:16274-16280.
191. Hadley TJ, Peiper SC: From malaria to chemokine receptor: the emerging physiologic role of the Duffy blood group antigen. Blood 1997;89:3077-3091.
192. de Winter RJ, Manten A, de Jong YP, Adams R, van Deventer SJH, Lie KI (1997) Interleukin 8 released after acute myocardial infarction is mainly bound to erythrocytes. Heart 1997;78:598-602.
193. aLe Van Kim C, Tournamille C, Kroviarski Y, Cartron JP, Colin Y: The 1.35-kb and 7.5- kb Duffy mRNA isoforms are differently regulated in various regions of brain, differ by the length of their 5' untranslated sequence, but encode the same polypeptide. Blood 1997;90:28551-2853.
194. Peiper SC, Wang Z, Neote K, Martin AW, Showel HJ, Conklyn MJ, Ogborne K et al: The Duffy Antigen/Receptor for Chemokines (DARC) is expressed in endothelial cells of Duffy negative individuals who lack the erythrocyte receptor. J Exp Med 1995;81:1311-1317.
195. Middleton J, Neil S, Wintle J, dark-Lewis I, Moore H, Lam C, Auer M, Hub E, Rot A: Transcytosis and surface presentation of IL-8 by venular endothelial cells. Cell 1997;91:385-395.
196. Desbaillets I, Diserens AC, de Tribolet N, Hamou MF, Van Meir EG: Upregulation of interleukin 8 by oxygen-deprived cells in glioblastoma suggest a role in leukocyte activation, chemotaxis, and angiogenesis. J Exp Med 1997;186:1201-1212.
197. Bates P: Chemokine receptors and HIV-1: an attractive pair? Cell 1996;86:l-3.
198. Alizon M: Récepteurs de chimiokines et entrée du VIH. Virologie 1997;1:471-479.
199. Dragic T, Picard L, Alizon M: Proteinase resistant factors in human erythrocyte membranes mediate CD4-dependent fusion with cells expressing human immunodeficiency virus type 1 enveloppe protein. J Virol 1995;69:1013-1018.
200. Puri A, Hug P, Munoz-Barroso I, Blumenthal R: Human erythrocyte glycolipids promote HIV-1 envelope glycoprotein-mediated fusion of CD4+ cells. Biochem Biophy Res Commun 1998;242:219-225.
201. Iwamoto S, Li J, Omi T, Ikemoto S, K E: Identification of a novel exon and spliced form of Duffy mRNA that is the predominant transcript in both erythroid and postcapillary venule endothelium. Blood 1996;87:378-385.
202. Tournamille C, Le Van Kim C, Gane P, Cartron JP, Colin Y: Molecular basis and PCR-DNA typing of the Fya/Fyb blood group polymorphism. Hum Genet 1995;95:407-410.
203. Mallinson G, Soo KS, Schall TJ, Pisacka M, Anstee DJ: Mutations in the erythrocyte chemokine receptor (Duffy) gene: the molecular basis of the Fya/Fyb antigens and identification of a deletion in the Duffy gene of an apparently healthy individual with the Fy(a-b-) phenotype. Br J Haematol 1995;90:823-829.
204. Toumamille C, Le Van Kim C, Gane P, Le Pennec PY, Roubinet F, Cartron JP, Colin Y: Arg89Cys substitution results in very low membrane expression of the Duffy Antigen/Receptor for Chemokines in Fyx individuals. Vox Sang, this issue (abstr. XXV ISBT Congress, Oslo, June 27-July 2), 1998.Submitted.
205. Chaudhuri A, Polyakova J, Zbrzezna V, Pogo OA: The coding sequence of Duffy blood group gene in human and simians : restriction fragment length polymorphism, antibody and malaria specificities, and expression in non erythroid tissues in Duffy-negative individuals. Blood 1995;85:615-621.
206. Tournamille C, Colin Y, Cartron JP, Le Van Kim C: Disruption of a GATA motif in the Duffy gene promoter abolishes erythroid gene expression in Duffy-negative individuals. Nature Genet 1995;10:224-228.
207. Chaudhuri A, Soren N, Elkjaer ML, Zbrzezna V, Fang F Pogo OA: Detection of Duffy antigen in the plasma membranes and caveolae of vascular endothelial and epithelial cells of nonerythroid organs. Blood 1997;89:701-712.
208. Wasniowska K, Blanchard D, Janvier D, Wang ZX, Peiper SC, Hadley TJ, Lisowska E: Identification of the Fy6 epitope recognized by two monoclonal antibodies in the n- terminal extracellular portion of the Duffy antigen receptor for chemokines. Mol Immunol 1996;33:917-923.
209. Lu ZH, Zi-xuan W, Horuk R, Hesselgesser J, Yan-chun L, Hadley TJ, Peiper SC: The promiscuous chemokine binding profile of the Duffy Antigen/Receptor for Chemokines is primarily localized to sequences in the amino-terminal domain. J Biol Chem 1995;270:26239-26245.
210. Pogo AO, Chaudhuri A: The Duffy blood group system and its extensions in nonhuma primates;. In "Molecular biology and evolution of blood group and MHC antigens in Primates" (Blancher, Klein and Socha, eds), Springer verlag (Berlin), 1997.
211. Luo H, Chaudhuri A, Johnson KR, Neote K, Zbrzezna V, He Y, Pogo OA : Cloning, characterisation, and mapping of a murine promiscuous chemokine receptor gene : homolog of the human Duffy gene. Genome Res 1997;7:932-941.
212. Parsons SF, Mallinson G, Judson PA, Anstee DJ, Tanner MJA, Daniels GL: Evidence that the Lub blood group antigen is located on red cell membrane glycoproteins of 85 and 78 kd. Transfusion 1987;27:61-63.
213. Daniels G, Khalid G : Identification, by immunoblotting, of the structures carrying Lutheran and Para-Lutheran blood group antigens. Vox Sang 1989;57:137-141.
214. Daniels G : Evidence that the Auberger blood group antigens are located on the Lutheran glycoproteins. Vox Sang 1990;58:56-60.
215. Parsons SF, Mallinson G, Holmes CH, Houlihan JM, Simpson KL, Mawby WJ, Spurr NK, Wame D, Barclay AN, Anstee DJ: The Lutheran blood group glycoprotein, another member of the immunoglobulin superfamily, is widely expressed in human tissues and is developmentally regulated in human liver. Proc Natl Acad Sci USA 1995;92:5496-5500.
216. Campbell IG, Foulkes WD, Senger G, Trowsdale J, Garin-Chesa P, Rettig, W J: Molecular cloning of the B-CAM cell surface of epithelial cancers: a novel member of the immunoglobulin superfamily. Cancer Res 1994;54:5761-5765.
217. Rahuel C, Le Van Kim C, Mattei MG, Cartron JP, Colin Y: A unique gene encodes spliceoforms of the Basal cell adhesion molecule cell surface glycoprotein of epithelial cancer and of the Lutheran blood group glycoprotein. Blood 1996;88:1865-1872.
218. El Nemer W, Rahuel C, Colin Y, Gane P, Cartron JP, Le Van Kim C: Organization of the human LU gene and molecular basis of the Lua/Lub blood group polymorphism. Blood 1997;89:4608-4616.
219. Parsons SF, Mallinson G, Daniels GL, Green CA, Smythe JS, Anstee DJ: Use of domaindeletion mutants to locate Lutheran blood group antigens to each of the five immunoglobulin superfamily domains of the Lutheran glycoprotein: Elucidation of the molecular basis of the Lua/Lub and the Aua/Aub polymorphisms. Blood 1997;89:4219-4225.
220. Rettig WJ, Garin-Chesa P, Bersford HR, Oettgen H, Melamed MR, Old L: Cell-surface glycoproteins of human sarcomas: differential expression in normal and malignant tissues ans cultured cells. Proc Natl Acad Sci USA 1988;85:3110-3114.
221. Chesa-Garin P, Sanz-Moncasi MP, Campbell IG, Rettig WJ: Non polarized expression of basal cell adhesion molecule B-CAM in epithelial ovarian cancers. Int J Oncol 1994;5:1261-1266.
222. Telen MJ: Lutheran antigens, lutheran regulatory genes, and lutheran regulatory gene targets. In "Molecular basis of major human blood group antigens" (Cartron JP, Rouger P, eds), Blood Cell Biochemistry vol 6, pp. 281-297, Plenum Press, NY, 1995.
223. Mallinson G, Green CA, Okubo Y, Daniels GL: The molecular background of recessive Lu(a-b-) phenotype in a Japanese family. Transf Medecine 1997;7 (suppl 1):18 (abst).
224. Mulley JC, Norman PC, Tippett P, Beal RW. A regional localization for an X-linked suppressor gene (XS) for the Lutheran blood group. Hum Genet 1988;78:127-129.
225. Lehmann JM, Riethmüller G, Johnson JP: MUC18, a marker of tumor progression in human melanoma, shows sequence similarity to the neural cell adhesion molecules of the immunoglobulin superfamily. Proc Natl Acad Sci (USA) 1989;86:9891-9895.
226. Tanaka H, Matsui T, Agata A, Tomura M, Kubota I, McFarland KC, Kohr B, Lee A, Phillips HS, Shelton DL: Molecular cloning and expression of a novel adhesion molecule, SC1. Neuron 1991;7:535-545.
227. Bowen MA, Patel DD, Li X, Modrell B, Malacko AR, Wang WC, Marquardt H, Neubauer M, Pesando JM, Francke U, Haynes BF, Aruffo A: Cloning, mapping, and characterization of activated leukocyte-cell adhesion molecule (ALCAM), a CD6 ligand. J Exp Med 1995;181:2213-2220.
228. Udani M, Jefferson S, Daymont C, Zen Q, Telen MJ: B-CAM/Lu protein: a novel laminin receptor overexpressed by sickle erythrocytes, Blood 1996;88 (suppl 1):6a (abstr.), 1996
229. El Nemer W, Gane P, Colin Y, Bony V, Rahuel C, Galactéros F, Cartron JP, Le Van Kim C: The Lutheran blood group glycoproteins, the erythroid receptors for laminin, are adhesion molecules. J Biol Chem 1998; in press.
230. Zen Q., Udani M., Cottman., Fraser R., Truskey G., and Telen MJ: B-CAM/LU protein; a single IgSF domain and copy number but not the cytoplasmic region are critical for laminin binding. Blood 1997;90 (suppl 1, part 1): 604a (abstr.).
231. Southcott MJG, Parsons SF, Anstee DJ, Tanner MJ: Lutheran glycoprotein, a cell adhesion molecule that binds laminin with high affinity is expressed on late erythrocyte precursors and appears after band 3. Blood 1997;90 (suppl 1):175b (abstr.).
232. Bony V, Gane P, Ghamberg CG, Cartron JP, Bailly P; Time-course expression of human blood group antigens during erythroid differentiation. ISH-EHA Combined Haematology Congress, July 4-8, Amsterdam, The Netherlands, 1998 (abstr.).
233. Solovey A, Lin Y, Browne P, Choong S, Wayner E, Hebbel RP: Circulating activated endothelial cells in sickle cell anemia. N Engl J Med 1997;337:1584-1590.
234. Styles LA, Lubin B, Vichinsky E, Lawrence S, Hua M, Test S, Kuypers F: Decrease of very late activation antigen-4 and CD36 on reticulocytes in sickle cell patients treated with hydroxyurea. Blood 1997;89:2554-2559.
235. Mecham RP: Receptors for laminin on mammalian cells. FASEB J 1991;5:2538- 2546.
236. Yurchenko, P.D., O'Rear J: Supramolecular organization of basement membranes In " Molecular and Cellular Aspects of Basement Membranes" (Rohrbach DH, Timpl R, eds), pp121-146, Academic Press, San Diego, 1993.
237. Rieger R, Edenhofer F, Lasmèzas CI, Weiss S: The human 37-kDa laminin receptor precursor interacts with the prion protein in eukaryotic cells, Nature Med 1997;3:1383- 1388.
238. Moore S: Identification of red cell membrane components associated with rhesus blood group antigen expression. In "Red Cell Glycoconjugates and Related Genetic Markers" (Cartron JP, Rouger P, Salmon Ch, eds), pp.97-106, Librairie Arnette, Paris, 1983.
239. Mallinson G, Martin PG, Anstee DJ, Tanner MJA, Merry AH, Tills D, Sonneborn HH: Identification and partial characterization of the human erythrocyte membrane component(S) that express the antigens of the LW blood group system, Biochem J 1986;234:649-652.
240. Konighaus GJ, Holland TL: The effect of dithiothreitol on the LW antigen. Transfusion 1984;24:536-537.
241. Bloy C, Hermand P, Blanchard D, Cherif-Zahar B, Goossens D, Cartron JP: Surface orientation and antigen properties of Rh and LW polypeptides of the human erythrocyte membrane. J Biol Chem 1990;265:21482-21487.
242. Bloy C, Hermand P, Chérif-Zahar B, Sonnebom HH, Cartron JP: Comparative analysis by two-dimensional iodopeptide mapping of the RhD protein and LW glycoprotein. Blood 1990;75, 2245-2249.
243. Race RR, Sanger R: Modern concept of the Rh blood group system. Ann New York Acad Sci 1965;127:884-891.
244. Bailly P, Hermand P, Callebault I, Sonnebom HH, Khamlichi S, Momon JP, Cartron JP: The LW blood group glycoprotein is homologous to intercellular adhesion molecules. Proc Natl Acad Sci, USA 1994;91:5306-5310.
245. Hermand P, Le Pennec PY, Rouger P, Cartron JP, Bailly P: Characterization of the gene encoding the human LW blood group protein in LW+ and LW- phenotypes, Blood 1996;87:2962-2967.
246. Hermand P, Gane P, Mattei MG, Sistonen P, Cartron JP, Bailly P: Molecular basis and expression of the LWa/LWb blood group polymorphism. Blood 1995;86:1590-1594.
247. 244a Gahmberg CG, Tolvanen M, Nortamo P, Li R, Kantor C, Xie J, Kotovuori P, Puustinen A, Valmu L, Ylänne J, Tontti E: The intercellular adhesion molecules (ICAMs). In "Adhesion receptors as therapeutic targets" (MA Horton, ed), pp.37-59, CRC Press, New York, 1996.
248. 244b Gahmberg CG, Tolvanen M, Kotovuori P: Leukocyte adhesion. Structure and function of human leukocyte 2-integrins and their cellular ligands. Eur J Biochem 1997;245:215-232.
249. Staunton DE, Dustin ML, Erickson HP, Springer TA: The arrangement of the immunoglobulin-like domains of ICAM-1 and the binding sites for LFA-1 and rhino-virus. Cell 1990;61:243-254.
250. Casasnovas JM, Springer TA, Liu JH, Harrison SC, Wang JH: Crystal structure of ICAM-2 reveals a distinctive integrin recognition surface. Nature 1997;387:312-315.
251. Bailly P, Tontti E, Hermand P, Cartron JP, Gahmberg CG: The red cell LW blood group glycoproteins is an intracellular adhesion molecule (ICAM-4) which binds to CD11/CD18 leucocyte integrins. Eur J Immunol 1995;25:3316-3320.
252. Stanley P, Hogg N: The I domain of integrin LFA-1 interacts with ICAM-1 at residue Glu34 but not Gin-73. J Biol Chem 1998;273:3358-3362.
253. Kraulis PJ: Molscript: a program to produce both detailed and schematic plots of protein structures. J Appl Crystallog 1991;D50:869
254. Berendt AR, McDowall A, Craig AG, Bates PA, Sternberg MJE, Marsh K, Newbold CI, Hogg N: The binding site on ICAM-1-infected erythrocytes overlaps, but is distinct, from the LFA-1 binding site. Cell 1992;68:71-81.
255. Ockenhouse CF, Belageri R, Springer TA, Staunton DE: Plasmodium falciparum-infected erythrocytes bind ICAM-1 at a site distinct from LFA-1, Mac-1, and humar rhinovirus. Cell 1992;68:63-69.
256. Van den Vieren M, Le Trong H, Wood CL Moore PF, St John T, Staunton DE, Gallatin WM: A novel leukointegrin, d 2, binds preferentially to ICAM-3. Immunity 1995;3:683-690.
257. Vuillet-Gaugler MH, Breton-Gorius J, Vainchenker W, Guichard J, Leroy C, Tchernia G, Coulombel L: Loss of attachment to fibronectin with terminal human erythroid differentiation. Blood 1990;75:865-873.
258. Rosemblatt M, Vuillet-Gaugler MH, Leroy C, Coulombel L: Co-expression of two fibronectin receptors, VLA-4 and VLA-5, by immature human erythroblastic precursor cells. J Clin Invest 1991;87:6-11.
259. Redman CM, Marsh WL: The Kell blood group system and the McLeod phenotype. Semin Hematol 1993;30:209-218.
260. Lee S: Molecular basis of Kell blood group phenotypes, Vox Sang 1997;73:1-11.
261. Redman CM, Marsh WL, Mueller KA, Avellino GP, Johnson CL: Isolation of Kell-active protein from the red cell membrane. Transfusion 1984;24:176-178.
262. Jaber A, Blanchard D, Goossens D, Bloy C, Lambin P, Rouger P, Salmon C, Cartron JP: Characterization of the blood group Kell (K1) antigen with a human monoclonal antibody. Blood 1989;73:1597-1602.
263. Redman CM, Avellino GP, Pfeffer SR, Mukhrjee TK, Nichols M, Rubistein P, Marsh WL: Kell blood group antigens are part of a 93,000 dalton red cell membrane protein. J Biol Chem 1986;261:9521-9525.
264. Marsh WL, Redman CM: Recent developments in the Kell blood group system. Transfus Med Rev 1987;1:4-20.
265. Branch DR, Sy Siok Hian AL, Petz LD: Unmasking of Kx antigen by reduction of disulphide bonds on normal and McLeod red cells. Br J Haematol 1985;59:505-512.
266. Khamlichi S, Bailly P, Blanchard D, Goossens D, Cartron JP, Bertrand O: Purification and partial characterization of the erythrocyte Kx protein deficient in Mcleod patients. Eur J Biochem 1995;228:931-934.
267. Lee S, Zambas ED, Marsh WL, Redman CM: Molecular cloning and primary structure of Kell blood group protein. Proc. Natl. Acad. Sci. USA 1991;88:6353-6357.
268. Advani H, Zamor J, Judd WJ, Johnson CL, Marsh WL: Inactivation of Kell blood group antigens by 2-aminoethylisothiouronium bromide. Br J Haematol 1982;51:107-115.
269. Branch DB, Muensch HA, Sy Siok Hian AL, Petz LD: Disulfide bonds are a requirement for Kell and Cartwright (Yta) blood group antigen integrity. Br J Haematol 1983;54:573-578.
270. Russo DCW, Lee S, Reid M, Redman CM: Topology of Kell blood group protein and the expression of multiple antigens by transfected cells. Blood 1994;84:3518-3523.
271. Busch SJ, Sassone-Corsi P: Dimers, leucine zippers and DNA-binding domains. Trends in Genet 1990;6:36-41.
272. Lee S, Zambas E, Green ED, Redman C: Organization of the gene encoding the human Kell blood group protein. Blood 1995;85:1364-1370.
273. Lee S, Zambas ED, Marsh WL, Redman CM: The human Kell blood group gene maps to chromosome 7q33 its expression is restricted to erythroid cells. Blood 1993;81:2804-2809.
274. Vaughan J., Manning M, Warwick R, Letsky EA, Murray NA, Roberts IAG (1996) Inhibition of erythroid progenitor cells by anti-Kell antibodies in fetal alloimmune anemia. N Engl J Med 1998;338:798-803.
275. Weiner CP, Widness JA: Decreased fetal erythropoiesis and hemolysis in Kell hemolytic anemia. Am J Obstet Gynecol 1996;174:547-551.
276. Vaughan J., Warwick R, Letsky EA, Nicolini U, Rodeck CH, Fisk NM: Erythropoietic suppression in fetal anemia be cause of Kell alloimmunization. Am J Obstet Gynecol 1994:171;247-252.
277. Lee S, Wu X, Zelinski T, Redman CM: Molecular basis of the Kell (K1) phenotype, Blood 1995;85:912-916.
278. Lee S, Bennett PR, Overton T, Warwick R, Wu X, Redman CM: Prenatal diagnosis of Kell blood group genotypes: KEL1 and KEL2. Am J Obstet Gynecol 1996;17:455-459.
279. Hessner MJ, McFarland JG, Endean DJ: Genotyping of KE1 and KEL2 of the human Kell blood group system by polymerase chain reaction with sequence-specific primers. Transfusion 1996;36:495-499.
280. Avent ND, Marin PG: Kell typing by allele-specific PCR (ASP). Br J Haematol 1996;93:728-730.
281. Lee S., Naime D, Reid M, Redman CM: The Kel24 and Kell4 alleles of the Kell blood group system. Transfusion 1997;37:1035-1038.
282. Turner AJ, Tanzawa K: Mammalian membrane metallopeptidases : NEP, ECE, Kell, and PEX, FASEB J 1997;11:355-364.
283. Xu D, Emoto N, Giaid A, Slaughter C, Kaw S, deWit D, Yanagisawa M: ECE-1 : a membrane-bound metalloprotease that catalyses the proteolytic activation of big Endothelin-1. Cell 1994;78:473-485.
284. The HYP Consortium: A gene (PEX) with homologies to endopeptidases is mutated in patients with X-linked hypophosphatemic rickets. Nature Genet. 1995;11:130-136.
285. Hardie RJ, Pullon HWH, Harding AE, Owen JS, Pires M, Daniels GL, Imai Y, Misra VP, King RHM, Jacobs JM, Tippett P, Duchen LW, Thomas PK, Marsden CD: Neuroacan-thocytosis a clinical, haematological and pathological study of 19 cases, Brain 1991;114:13-49.
286. Witt TN, Danek A, Reiter M, Heim MU, Dirschinger JD, Olsen EGJ: McLeod syndrome: a distinct form a neuroacanthocytosis. J Neurol 1992;239:302-306.
287. Redman CM, Marsh WL, Scarborough A, Johnson CI, Rabin BJ, Overbeeke M: Biochemical studies on McLeod phenotype red cells and isolation of Kx antigen. Br J Haematol 1988;68:131-136.
288. Ho M, Chelly J, Carter N, Danek A, Crocker P, Monaco AP: Isolation of the gene for McLeod syndrome that encodes a novel membrane transport protein. Cell 1994;77:869-880.
289. Carbonnet F, Hattab C, Collec E, Le Van Kim C, Cartron JP, Bertrand O: Immunochemical analysis of the Kx protein from human red cells of different Kell phenotypes using antibodies raised against synthetic peptides. Br J Haematol 1997;96:857-863.
290. Carbonnet F, Blanchard D, Hattab C, Cochet S, Petit-Leroux Y, Loirat MJ, Cartron JP, Bertrand O: A murine monoclonal antibody against human Kx protein. XXVth Congress of the Int Soc Blood Transfusion, June 27-July 2nd, Oslo, Norway, 1998a (abstract).
291. Francke U, Ochs HD, De Martinville B, Giacalone J, Lindgren V, Distèche C, Pagon RA, Hofker MH, Van Ommen GJB, Pearson PL, Wedgwood RJ: Minor Xp21 chromosome deletion in a male associated with expression of Duchenne muscular dystrophy, chronic granulomatous disease, retinitis pigmentosa, and McLeod syndrome. Am J Hum Genet 1985;37:250-267.
292. Bertelson CJ, Pogo AO, Chaudhuri A, Redman CM, Banerjee D, Symman WA, Simon T, Kunkel LM: Localizationof the McLeod locus (XK) within Xp21 by deletion analysis. Am J Hum Genet 1988;423:703-711.
293. De Sainte-Basile G, Bohler MC, Fischer A, Cartron J, Dufier JL, Griscelli C, Orkin SH: Xp21 DNA microdeletion in a patient with chronic granulomatous disease, retinitis pigmentosa, and McLeod phenotype. Hum Genet 1988;80:85-89.
294. Ho MF, Monaco AP, Blonden LAJ, Van Ommen GJB, Affara NA, Ferguson-Smith MA, Lehrach H: Fine mapping on the McLeod locus (XK) to a 150-380-kb region in Xp21. Am J Hum Genet 1992;50:317-330.
295. Ho MF, Chalmers RM, Davis MB et al. : A novel point mutation in the McLeod syndrome gene in neuroacanthocytosis. Ann Neurol 1996;39:672-675.
296. Daniels GL, Weinauer F, Stone C, Ho M, Green CA, Jahn-Jochem H, Hoffner R, Monaco AP: A combination of the effects of rare genotypes at the XK and KEL blood group loci results in the absence of Kell system entigens from the red blood cells. Blood 1996;88:4405-4050.
297. Carbonnet F, Hattab C, Cartron JP, Bertrand O: Kell and Kx, two disulfide-linked proteins of the human erythrocyte membrane are phosphorylated in vivo. Biochem Biophys Res Commun 1998b; in press
298. Peters LL, Shivdasani RA, Liu SC, Hanspal M, John KM, Gonzalez JM, et al: Anion exchanger 1 (Band 3) is required to prevent erythrocyte membrane surface loss but not to form the membrane skeleton. Cell 1996;86:917-927.
299. Southgate CD, Chishti AH, Michell B, Yi SJ, Palek Y: Targeted disruption of the murine erythroid band 3 gene results in spherocytosis and severe haemolytic anaemia despite a normal membrane skeleton. Nature Genet 1996;14:227-230.
300. Lindberg FP, Bullord DC, Caver TE et al: Decreased resistance to bacterial infection and granulocyte defects in IAP-deficient mice, Science 1996;274:795-798.
301. Igakura T, Kadomatsu K, Taguchi O, Muramatsu H, Kaname T, Miyauchi T, Yamamura K, Arimura K, Muramatsu T: Role of basigin, a member of the immunoglobulin super-family, in behavior as to irritating odor, lymphocyte response, and blood-brain barrier. Biochem Biophys Res Commun 1996;224:33-36.
302. Ma T, Yank B, Gillepsie AM, Carlson EJ, Epstein CJ, Verkman AS: Severely impaired urinary concentrating ability in transgenic mice lacking aquaporin-1 water channels. J Biol Chem 1998;273:4296-4299.
303. Preston GM, Smith BL, Zeidl ML, Moulds JJ: Mutations in aquaporin-1 in phenotypically normal humans without functional CHIP water channels. Science 1994;265:1585-1587.
304. Mathai JC, Mori S, Smith BL, Preston GM, Mohandas N, Collins M, van Zijl PCM, Zeidl ML, Agre P: Functional analysis of aquaporin-1 deficient red cells. The Colton-null phentotype. J Biol Chem 1996;271:1309-1313.